KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Payables: 2020-2024

Historic Payables for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $14.2 million.

  • Ginkgo Bioworks Holdings' Payables fell 31.82% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.3 million, marking a year-over-year decrease of 36.92%. This contributed to the annual value of $14.2 million for FY2024, which is 51.98% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Payables stood at $14.2 million for FY2024, which was up 51.98% from $9.3 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Payables registered a high of $14.2 million during FY2020, and its lowest value of $8.2 million during FY2021.
  • In the last 3 years, Ginkgo Bioworks Holdings' Payables had a median value of $10.5 million in 2022 and averaged $11.3 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Payables slumped by 42.30% in 2021 and then spiked by 51.98% in 2024.
  • Ginkgo Bioworks Holdings' Payables (Yearly) stood at $14.2 million in 2020, then slumped by 42.30% to $8.2 million in 2021, then grew by 27.62% to $10.5 million in 2022, then declined by 10.79% to $9.3 million in 2023, then spiked by 51.98% to $14.2 million in 2024.